Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sir David Jack: an extraordinary drug discoverer and developer.

× No keyword cloud information.

41 in total

1. The US Food and Drug Administration and long-acting beta2-agonists: the importance of striking the right balance between risks and benefits of therapy?

Authors: Robert F Lemanske; William W Busse
Journal: J Allergy Clin Immunol Date: 2010-08-07 Impact factor: 10.793

2. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists.

Authors: C P Page
Journal: Lancet Date: 1991-03-23 Impact factor: 79.321

3. Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.

Authors: Badrul A Chowdhury; Sally M Seymour; Mark S Levenson
Journal: N Engl J Med Date: 2011-06-30 Impact factor: 91.245

4. The pharmacology of two novel long-acting phosphodiesterase 3/4 inhibitors, RPL554 [9,10-dimethoxy-2(2,4,6-trimethylphenylimino)-3-(n-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one] and RPL565 [6,7-dihydro-2-(2,6-diisopropylphenoxy)-9,10-dimethoxy-4H-pyrimido[6,1-a]isoquinolin-4-one].

Authors: Victoria Boswell-Smith; Domenico Spina; Alec W Oxford; Mike B Comer; Esther A Seeds; Clive P Page
Journal: J Pharmacol Exp Ther Date: 2006-05-08 Impact factor: 4.030

5. Salmeterol, a novel, long-acting beta 2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo.

Authors: D I Ball; R T Brittain; R A Coleman; L H Denyer; D Jack; M Johnson; L H Lunts; A T Nials; K E Sheldrick; I F Skidmore
Journal: Br J Pharmacol Date: 1991-11 Impact factor: 8.739

Review 6. International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes.

Authors: R A Coleman; W L Smith; S Narumiya
Journal: Pharmacol Rev Date: 1994-06 Impact factor: 25.468

Review 7. Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature.

Authors: G R Martin; P P Humphrey
Journal: Neuropharmacology Date: 1994 Mar-Apr Impact factor: 5.250

Review 8. Review article: the therapeutic potential of 5-HT3 receptor antagonists in the treatment of irritable bowel syndrome.

Authors: P P Humphrey; C Bountra; N Clayton; K Kozlowski
Journal: Aliment Pharmacol Ther Date: 1999-05 Impact factor: 8.171

Sir David Jack: an extraordinary drug discoverer and developer.